Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 2443

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act with respect to CLIA waiver study design guidance for in vitro diagnostics.
About This Bill
Committee
Latest Action · May 22, 2015
Referred to the Subcommittee on Health.
Congress
114th (2015–2017)
Introduced
May 19, 2015
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
This bill requires the Department of Health and Human Services to publish guidance that revises “Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices” and includes guidance on using comparable performance between types of users to demonstrate the accuracy of a medical device.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.